Pulse Biosciences, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $20.8M | $12.7M |
| Jun 2022 | — | $23.4M | $14.8M |
| Sep 2022 | — | $6.2M | $69.2M |
| Dec 2022 | — | $-2.2M | $61.1M |
| Mar 2023 | — | $-10.7M | $54.1M |
| Jun 2023 | — | $60.5M | $58.7M |
| Sep 2023 | — | $52.1M | $50.4M |
| Dec 2023 | — | $44.4M | $44.4M |
| Mar 2024 | — | $36.3M | $34.9M |
| Jun 2024 | — | $27.0M | $26.2M |
| Sep 2024 | — | $79.1M | $79.0M |
| Dec 2024 | — | $114.9M | $118.0M |
| Mar 2025 | — | $118.5M | $119.3M |
| Jun 2025 | — | $104.5M | $106.3M |
| Sep 2025 | — | $92.7M | $95.2M |
| Dec 2025 | — | $80.7M | $80.7M |
| Mar 2026 | — | $66.3M | $68.3M |
| Jun 2026 | — | $99.5M | $101.6M |